We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 19, 2022

Stereotactic Radiosurgery vs Whole Brain Radiotherapy in Patients With Intracranial Metastatic Disease and SCLC

The Lancet Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Oncology
Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis
Lancet Oncol 2022 May 26;[EPub Ahead of Print], K Gaebe, AY Li, A Park, A Parmar, BH Lok, A Sahgal, KKW Chan, AW Erickson, S Das

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading